This Apple Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Monday
Credo Technology
TE Connectivity plc
AgomAb Therapeutics NV ADR
SpaceX
Faeth Therapeutics, Inc.
Credo Technology CRDO | 0.00 | |
TE Connectivity plc TEL | 0.00 | |
AgomAb Therapeutics NV ADR AGMB | 0.00 | |
SpaceX SPCX | 0.00 | |
Faeth Therapeutics, Inc. FTH | 0.00 |
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- Evercore ISI Group analyst Amit Daryanani downgraded TE Connectivity PLC (NYSE:TEL) from Outperform to In-Line and slashed the price target from $260 to $230. TE Connectivity Sciences shares closed at $217.64 on Thursday. See how other analysts view this stock.
- KGI Securities downgraded Apple Inc. (NASDAQ:AAPL) from Outperform to Hold and announced a $315 price target. Apple shares closed at $298.01 on Thursday. See how other analysts view this stock.
- TD Cowen analyst Bryan Bergin downgraded Accenture plc (NYSE:ACN) from Buy to Hold and cut the price target from $258 to $150. Accenture shares closed at $127.98 on Thursday. See how other analysts view this stock.
Considering buying TEL stock? Here’s what analysts think:
Photo via Shutterstock
